BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.170
-0.230 (-16.43%)
At close: Aug 17, 2026, 4:00 PM EDT
1.140
-0.030 (-2.55%)
Pre-market: Aug 18, 2026, 7:47 AM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $8.82 million as of August 18, 2026. Its market cap has decreased by -28.84% in one year.
Market Cap
8.82M
Enterprise Value
122.01K
1-Year Change
-28.84%
Ranking
Category
Stock Price
$1.17
ChartMarket Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $8.82M, a decrease of -83.03%. That is a compound annual growth rate of -25.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 8.82M | 1.42% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 11.23M |
| OSR Health | 11.09M |
| BioCardia | 11.08M |
| Vistagen Therapeutics | 10.98M |
| IN8bio | 10.84M |
| GT Biopharma | 10.67M |
| Instinct Bio Technical Company Holdings | 10.57M |
| Theriva Biologics | 10.46M |